mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.008 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.008 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.008 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.008 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.009 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.009 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.009 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |